Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC
Sponsor: Pfizer
Summary
The objective of this study is to describe patient demographics, clinical characteristics, treatment patterns and clinical outcomes of adult female patients who have received palbociclib combination treatments as first line therapy, regardless of combination partner and labelled use in real world settings across Brazil.
Official title: TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS IN BRAZIL RECEIVING PALBOCICLIB COMBINATIONS FOR HR+/HER2- ADVANCED/METASTATIC BREAST CANCER IN REAL WORLD SETTINGS
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
121
Start Date
2022-05-30
Completion Date
2023-05-02
Last Updated
2026-06-02
Healthy Volunteers
No
Conditions
Locations (14)
NOB - Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, Brazil
Ensino E Terapia de Inovação Clínica Amo - Ética
Salvador, Estado de Bahia, Brazil
Instituto D´Or de Pesquisa E Ensino - Brasília
Brasília, Federal District, Brazil
Hospital Sírio Libanês
Brasília, Federal District, Brazil
Hospital Araújo Jorge
Goiânia, Goiás, Brazil
Oncoclínicas Do Brasil Servicos Médicos S/A - Oncocentro
Belo Horizonte, Minas Gerais, Brazil
Centro Especializado de Oncologia de Florianópolis
Florianópolis, Brazil
Instituto de Mastologia e Oncologia
Goiânia, Brazil
Instituto D'or de Pesquisa e Ensino
Recife, Brazil
Centro de Tratamento de Tumores Botafogo
Rio de Janeiro, Brazil
Instituto D´or de Pesquisa e Ensino
Rio de Janeiro, Brazil
Instituto de Educação, Pesquisa e Gestão em Saúde
Rio de Janeiro, Brazil
Hospital Paulistano - INSTITUTO DE EDUCAÇÃO, PESQUISA E GESTÃO EM SAÚDE
São Paulo, Brazil
Hcor - Associação Beneficente Síria
São Paulo, Brazil